Wilkinson D S
Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.
Clin Lab Manage Rev. 1997 Sep-Oct;11(5):322-30.
Advances in automation and informatics will drive the implementation of new technology as we enter the 21st century. Five technologies which will have the greatest impact on the practice of laboratory medicine during the next decade include molecular diagnostics, near patient testing, image analysis, robotics, and information management. The list of molecular pathology tests with potential clinical utility expands daily. Some, such as tests for human immune deficiency virus (HIV) and hepatitis C virus, already are available as commercial kits. Quality assessment and proficiency testing programs still are evolving. DNA tests in oncology, such as T- and B-cell gene rearrangements and t(9;22) translocation, have proven useful in detecting small numbers of tumor cells and have demonstrated clinical utility in some circumstances. Tests for monogenetic diseases, such as sickle cell disease, are useful in planning antenatal management of mothers at risk. Screening tests for the genetic predisposition for certain forms of colon and breast cancer and Alzheimer's Disease are now possible. This suggests the potential for large scale screening of populations at risk. Continued improvements in biosensor technology and miniaturization will increase the ability to test for many analytes at or near the patient. The generally increased cost per test must be reconciled with the potential to decrease the overall cost of care by improved turnaround time. Computerized image analysis will radically change, and in some cases eliminate, manual clinical microscopy in urinalysis, hematology, immunohistochemistry, and cytology. Robotics will greatly decrease personnel requirements for repetitive tasks, such as specimen transport, processing, and aliquoting. We will process many specimens from start to finish without human intervention. Image management systems will allow archiving of diagnostic gross and microscopic images along with the traditional text descriptions and diagnosis. Telepathology will link smaller centers with expert consultants in tertiary centers. Voice recognition systems will obviate the need for transcriptionists. Modern database architectures will allow the clinical laboratory to measure performance effectiveness and clinical outcomes and will place laboratorians at the forefront of outcomes research. Hand-held devices will allow physicians to conveniently order laboratory tests and retrieve results, further decreasing the functional turnaround time for laboratory testing. All of these technologies will be expensive to implement, but well-planned deployment will both decrease cost and improve the quality of medical care.
随着我们步入21世纪,自动化和信息学的进步将推动新技术的应用。未来十年对检验医学实践影响最大的五项技术包括分子诊断、床边检测、图像分析、机器人技术和信息管理。具有潜在临床应用价值的分子病理学检测项目日益增多。其中一些检测,如人类免疫缺陷病毒(HIV)和丙型肝炎病毒检测,已有商业化试剂盒可供使用。质量评估和能力验证计划仍在不断发展。肿瘤学中的DNA检测,如T细胞和B细胞基因重排以及t(9;22)易位检测,已被证明在检测少量肿瘤细胞方面很有用,并在某些情况下显示出临床应用价值。单基因疾病检测,如镰状细胞病检测,有助于为有风险的母亲制定产前管理计划。现在可以进行某些形式的结肠癌、乳腺癌和阿尔茨海默病遗传易感性的筛查检测。这表明对高危人群进行大规模筛查具有可能性。生物传感器技术的持续改进和小型化将提高在患者处或患者附近检测多种分析物的能力。每次检测成本普遍增加的情况必须与通过缩短周转时间来降低总体医疗成本的潜力相协调。计算机化图像分析将从根本上改变,在某些情况下还将取代尿液分析、血液学、免疫组织化学和细胞学中的手动临床显微镜检查。机器人技术将大大减少对重复性任务的人员需求,如标本运输、处理和分装。我们将在无需人工干预的情况下从头到尾处理许多标本。图像管理系统将允许存档诊断大体和显微镜图像以及传统的文字描述和诊断。远程病理学将把较小的中心与三级中心的专家顾问联系起来。语音识别系统将不再需要转录员。现代数据库架构将使临床实验室能够衡量绩效有效性和临床结果,并使检验人员处于结果研究的前沿。手持设备将使医生能够方便地订购实验室检测并获取结果,进一步缩短实验室检测的功能周转时间。所有这些技术的实施成本都很高,但精心规划的部署将既能降低成本又能提高医疗质量。